Seven Eight Capital’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-11,009
Closed -$1.23M 670
2024
Q1
$1.23M Sell
11,009
-17,256
-61% -$2.06M 0.13% 249
2023
Q4
$3.67M Buy
28,265
+20,252
+253% +$2.79M 0.42% 55
2023
Q3
$1.31M Buy
+8,013
New +$1.41M 0.15% 177

Other funds holding ACLS

Seven Eight Capital's ACLS Position: Q2 2024 in Review

Seven Eight Capital sold out of Axcelis (ACLS) in Q2 2024, closing a stake of 11,009 shares — an estimated $1.23M sold.

Seven Eight Capital first reported a position in ACLS in Q3 2023 and held it in 3 quarters. The position peaked at $3.67M in Q4 2023. 390 funds tracked by Wall St. Rank hold ACLS as of Q2 2024.

  • Seven Eight Capital reported no remaining Axcelis position as of Q2 2024 after selling out during the quarter.
  • Seven Eight Capital sold 11,009 Axcelis shares in Q2 2024, an estimated $1.23M.
  • Seven Eight Capital first reported a position in Axcelis in Q3 2023 and held it in 3 quarters.
  • Seven Eight Capital's Axcelis position peaked at $3.67M in Q4 2023.
  • 390 funds tracked by Wall St. Rank held Axcelis as of Q2 2024.

Based on Seven Eight Capital's 13F filing for Q2 2024, filed 12 Aug 2024.